Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 2.992\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) COc1cc2c(cc1OC)C(c1ccccc1)N(C(=O)c1ccccc1F)CC2
(b) Cc1cccc(N2C(=O)CC(N(O)c3ccccc3)C2=O)c1
(c) CCCNC(=O)c1onc(CSc2ccc(F)cc2)c1C(=O)NC(C)C
Answer: c. CCCNC(=O)c1onc(CSc2ccc(F)cc2)c1C(=O)NC(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)c1onc(CSc2ccc(F)cc2)c1C(=O)NC(C)C
CCCNC(=O)c1onc(CSc2ccc(F)cc2)c1C(=O)NC(C)C
3-[(4-fluorophenyl)sulfanylmethyl]-4-N-propan-2-yl-5-N-propyl-1,2-oxazole-4,5-dicarboxamide